Detalles de la búsqueda
1.
Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity.
Blood
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38635762
2.
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
N Engl J Med
; 387(2): 132-147, 2022 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35660812
3.
Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trial.
Br J Haematol
; 204(4): 1429-1438, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38348544
4.
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.
Haematologica
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38721749
5.
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy.
Am J Hematol
; 99(5): 880-889, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38504387
6.
Associations of minor histocompatibility antigens with outcomes following allogeneic hematopoietic cell transplantation.
Am J Hematol
; 98(6): 940-950, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37052167
7.
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
Am J Hematol
; 98(1): 140-147, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35567778
8.
Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?
Br J Haematol
; 197(3): 326-338, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35286719
9.
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.
Haematologica
; 107(5): 1045-1053, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34382386
10.
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases.
Blood
; 133(7): 754-762, 2019 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30545834
11.
Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation?
Biol Blood Marrow Transplant
; 26(4): e77-e85, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31917272
12.
Myeloablative versus Reduced-Intensity Hematopoietic Cell Transplantation in Myelodysplastic Syndromes: Systematic Review and Meta-analysis.
Biol Blood Marrow Transplant
; 26(6): e138-e141, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32171885
13.
Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma.
Biol Blood Marrow Transplant
; 26(12): 2229-2236, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32920204
14.
Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients.
Biol Blood Marrow Transplant
; 26(11): 2011-2017, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32717431
15.
Relapse after Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma: Survival Outcomes and Factors Influencing Them.
Biol Blood Marrow Transplant
; 26(7): 1288-1297, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32135202
16.
Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes.
Biol Blood Marrow Transplant
; 26(5): 893-901, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31982543
17.
Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor Transplantation.
Biol Blood Marrow Transplant
; 26(9): 1670-1678, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32562858
18.
Summary of the Third Annual Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling.
Biol Blood Marrow Transplant
; 26(1): e7-e15, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31526843
19.
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States.
Biol Blood Marrow Transplant
; 26(8): e177-e182, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32438042
20.
Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia.
Biol Blood Marrow Transplant
; 26(7): e161-e166, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32389803